Category:NA-importance pharmacology articles
 | This is a maintenance category, used for maintenance of the Wikipedia project. It is not part of the encyclopedia and contains non-article pages, or groups articles by status rather than subject. Do not include this category in content categories. |
 | Administrators: Please do not delete this category as empty! This category may be empty occasionally or even most of the time. |
| Top | High | Mid | Low | NA | ??? |
| 120 | 880 | 3,126 | 6,558 | 2,447 | 3,473 |
Pages in category "NA-importance pharmacology articles"
The following 200 pages are in this category, out of approximately 2,447 total. This list may not reflect recent changes.
(previous page) (next page)Q
R
- Template talk:R from drug trade name
- Talk:R015-4513
- Template talk:Rabies
- Template talk:Racetams
- Category talk:Racetams
- Talk:Ramezol
- File talk:Rational harm assessment of drugs radar plot.svg
- Template talk:Recent changes in Pharmacology
- Category talk:Receptor agonists
- Category talk:Receptor heteromer ligands
- Category talk:Receptor modulators
- Template talk:Receptor modulators
- Category talk:Receptor tyrosine kinase inhibitors
- Talk:Recombinant subunit vaccine
- Category talk:Recreational drug metabolites
- Talk:Recreational use of ketamine
- Category talk:Redirect-Class pharmacology articles
- Category talk:Redirects from trade names of drugs
- Talk:Reditux
- File talk:Reduction of tropinone.png
- Talk:Regulacid
- Template talk:Regulation of therapeutic goods in the United States
- Template talk:Relative activities of estradiol and related estrogens at the estrogen receptors
- Template talk:Relative affinities and efficacies of estrogens at the ERα and ERβ
- Template talk:Relative affinities of anabolic steroids and related steroids
- Template talk:Relative affinities of estradiol and related estrogens at steroid hormone proteins
- Template talk:Relative affinities of estrogens for steroid hormone receptors and blood proteins
- Template talk:Relative affinities of estrogens for the estrogen receptors
- Template talk:Relative affinities of first-generation nonsteroidal antiandrogens for the androgen receptor
- Template talk:Relative affinities of hydroxyprogesterone and related steroids
- Template talk:Relative affinities of levonorgestrel and metabolites
- Template talk:Relative affinities of nandrolone and related steroids
- Template talk:Relative affinities of nandrolone and related steroids at the androgen receptor
- Template talk:Relative affinities of norethisterone, metabolites, and prodrugs
- Template talk:Relative affinities of noretynodrel, tibolone, and metabolites
- Template talk:Relative affinities of normethandrone and metabolites
- Template talk:Relative androgenic to anabolic activity in animals
- Template talk:Relative oral potencies of estrogens
- Template talk:Relative potencies of selected antiandrogens
- Category talk:Renin inhibitors
- Category talk:Reproductive toxicants
- Category talk:Reproductive toxins
- Wikipedia talk:Requested articles/Medicine/Pharmacology
- Talk:Respiratory stimulant
- Category talk:Respiratory system drug stubs
- Talk:Resporal
- Template talk:Retinoid receptor modulators
- Talk:Retrograde neurotransmission
- Talk:Reuptake inhibition
- Category talk:Revenue stamps
- Category talk:Reverse transcriptase inhibitors
- Category talk:Reversible inhibitors of MAO-A
- Talk:Revigor
- Talk:REVIGOR
- Talk:Revolution (pet medicine)
- Template talk:Risk factors in CD vs. UC
- Template talk:RNA antivirals
- Talk:RO5263397
- File talk:Robinson biosynthesis of tropane.png
- Talk:Robitussin
- File talk:Rocks of crack cocaine.jpg
- Category talk:Rodenticides
- Talk:Rohypnol
- Category talk:Romanian pharmacologists
- Talk:Rome 20
- Draft talk:Rowlands Pharmacy
- Category talk:Russian pharmacologists
- Category talk:Rwandan pharmacologists
S
- Talk:Safety cap (medicine)
- Talk:Safety monitoring
- Category talk:Salicylamides
- Category talk:Salicylic acids
- Talk:Saline Solution
- Talk:Sanamidol
- Category talk:Saudi Arabian pharmacologists
- Category talk:Schering-Plough
- Talk:Scottish Medicines Consortium
- Category talk:Scottish pharmacologists
- Talk:Secrepina
- Category talk:Sedatives
- Talk:Segazole
- Template talk:Selected biological properties of endogenous estrogens in rats
- Talk:Selective agonist
- Category talk:Selective estrogen receptor modulators
- Talk:Selective serotonin reuptake enhancer
- Talk:Selozok
- Category talk:Semisynthetic opioids
- Template talk:Serenics
- Talk:Serotonergic
- Category talk:Serotonin receptor agonists
- Category talk:Serotonin receptor antagonists
- Template talk:Serotonin receptor modulators
- Category talk:Serotonin–dopamine reuptake inhibitors
- Category talk:Serotonin–norepinephrine reuptake inhibitors
- Category talk:Serotonin–norepinephrine–dopamine reuptake inhibitors
- Talk:Setlers
- Category talk:Sex and drugs
- Category talk:Sexual dysfunction drugs
- Template talk:Sexual dysfunction pharmacotherapies
- Talk:SFC Lotion
- Talk:SGN-CD19A
- Draft talk:Shah Haris
- Draft talk:Shamitha Kusum Perera
- Category talk:Shaving cream brands
- Category talk:Shenyang Pharmaceutical University
- Category talk:Shenyang Pharmaceutical University alumni
- Category talk:Short stories about drugs
- File talk:Side effects of chronic use of Cocaine.png
- Template talk:Side effects of estramustine phosphate (EMC)
- Template talk:Side effects of estramustine phosphate (FDA)
- Template talk:Side effects of estrogen plus high- versus low-dose cyproterone acetate in women
- Category talk:Sigma agonists
- Template talk:Sigma receptor modulators
- Talk:Signaling molecule
- Talk:Sirtuins
- Talk:Sirturo
- Talk:Sleeping gas
- File talk:SmithBrothers 02.gif
- File talk:SmithBrothers 04.jpg
- Category talk:Smoking
- File talk:Smoking Crack.jpg
- Category talk:Social aspects of psychoactive drugs
- Template talk:Sodium channel blockers
- Talk:Sodium laurilsulfate
- Talk:Sodium nitrite (medical use)
- Template talk:Sodium-glucose transporter modulators
- Talk:Soliqua 100/33
- Draft talk:Somai Pharmaceuticals
- Category talk:Somatostatin inhibitors
- Category talk:Spanish pharmacologists
- Category talk:Species endangered by human consumption for medicinal or magical purposes
- Template talk:Spirolactone structures
- Template talk:Spironolactone
- Template talk:Spironolactone at steroid hormone receptors
- Talk:Spottle
- Category talk:Sri Lankan pharmacologists
- Category talk:Start-Class pharmacology articles
- Category talk:Statins
- Category talk:Steroid cyclic ketals
- Category talk:Steroid esters
- Category talk:Steroid ethers
- Template talk:Steroid hormones
- Category talk:Steroids
- Category talk:Stimulants
- Template talk:Stomatological preparations
- Talk:Strathclyde Institute of Pharmacy and Biomedical Sciences
- Template talk:Structural aspects of androgens and anabolic steroids
- Template talk:Structural aspects of progestogens used in clinical and veterinary medicine
- Template talk:Structural properties of major anabolic steroid esters
- Template talk:Structural properties of major testosterone esters
- Template talk:Structural properties of selected estradiol esters
- Category talk:Stub-Class pharmacology articles
- Category talk:Substance abuse
- Category talk:Substance dependence
- Category talk:Substance intoxication
- Category talk:Substituted amphetamines
- Talk:Sucraid
- Talk:Summary of Product Characteristics
- Talk:Sundown: The Future of Children and Drugs
- Template talk:Sunscreening agents
- Draft talk:Super-pharma-fr
- Category talk:Swedish pharmacologists
- Category talk:Swiss pharmacologists
- Talk:Symax
- Template talk:Sympatholytic antihypertensives
- Category talk:Sympathomimetic amines
- Template talk:Symporter inhibitors
- Talk:Synergy (pharmacology)
- Talk:Synphasic
- Category talk:Syntex
- Talk:Synthetic cannabinoid
- Category talk:Synthetic estrogens
- Category talk:Syrian pharmacologists
- Category talk:Systemic hormonal preparation stubs
T
- Template talk:TAAR ligands
- Category talk:TAAR1 agonists
- File talk:TAAR1 Amphetamine Dopamine.png
- Category talk:Tachykinin receptor antagonists
- Category talk:Taiho Pharmaceutical
- Category talk:Taiwanese pharmacologists
- Category talk:Takeda Pharmaceutical Company
- Talk:Tamiflu resistance in the 2009 flu pandemic
- Talk:Tardiferon
- Category talk:Tardive dyskinesia
- Template talk:Target ranges for hormone levels in hormone therapy for transgender women
- Template talk:Targeted cancer therapeutic agents
- Talk:Tasonermin
- Talk:Tazorac
- Category talk:Technetium-99m
- Talk:Tedec Ulceral
- Talk:TeGenero
